《半日總結》恆指跌87點 醫藥股走弱 中遠海控逆市揚
港股早市反覆偏軟。恆指低開233點,早段曾跌385點見21,200點,中午前跌幅曾收窄至47點見21,538點,半日跌87點或0.41%,報21,498點;國指跌55點或0.74%,報7,490點;恆生科技指數跌48點或1.02%,報4,752點。大市半日成交總額612.72億元,滬、深港通南下交易半日分別流入8.19億及10.62億元人民幣。
科技股方面,騰訊(00700.HK)升0.5%報349.2元,阿里巴巴(09988.HK)跌0.6%報116.3元,小米(01810.HK)升1.1%報13.32元,美團(03690.HK)、京東(09618.HK)及快手(01024.HK)各跌1%至1.3%。百度(09888.HK)及網易(09999.HK)各跌2.6%及2.3%,嗶哩嗶哩(09626.HK)及金蝶(00268.HK)各跌3.2%及4.7%。萬國數據(09698.HK)及金融壹賬通(06638.HK)各跌5.4%及7.5%。
手機相關股比亞迪電子(00285.HK)跌2.8%,5G概念股長飛光纖光纜(06869.HK)升5.6%。中遠海控(01919.HK)股價抽高近4.8%收11.38元,預報中期利潤增74.5%至647億人民幣。
汽車股個別發展,蔚來(09866.HK)跌4.2%,廣汽(02238.HK)及長汽(02333.HK)各升5.9%及2.7%。體育用品股李寧(02331.HK)及特步(01368.HK)各升3.3%及4.6%。消費股JS環球生活(01691.HK)及泡泡瑪特(09992.HK)各跌3.7%及4.2%。航空股國航(00753.HK)及南航(01055.HK)各反彈2.6%及3%。
醫藥股走軟,康哲藥業(00867.HK)及百濟神州(06160.HK)各跌5.3%及6.1%,藥明康德(02359.HK)跌3.6%,石藥(01093.HK)、復星醫藥(02196.HK)、藥明生物(02269.HK)及康希諾(06185.HK)各跌逾2%。
油價跌至12周低,中石油(00857.HK)及中海油(00883.HK)各跌1.1%及1.5%。電力股大唐發電(00991.HK)及中國電力(02380.HK)各升5.7%及5.9%,華電國際(01071.HK)升2.8%。
金融股方面,匯控(00005.HK)平收報49.1元,渣打(02888.HK)跌1.9%報54.8元,港交所(00388.HK)升0.2%報368.4元,友邦(01299.HK)跌0.1%報84.55元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.